• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Economics of Atopic Dermatitis: From Real-World Burden to Value-Driven Treatment Strategies

home / peer-exchange / the-economics-of-atopic-dermatitis-from-real-world-burden-to-value-driven-treatment-strategies

Experts discuss the clinical benefits of topical therapies in managing pediatric atopic dermatitis (AD), strategies to delay biologic treatments, and how health economics and outcomes research (HEOR) informs cost-effective treatment choices and healthcare resource optimization.

Atopic Dermatitis Treatment Challenges: Pediatric vs. Adult Patient Management and Healthcare Resource Utilization

EP. 1: Atopic Dermatitis Treatment Challenges: Pediatric vs. Adult Patient Management and Healthcare Resource Utilization

Brian Keegan, MD, PhD, FAAD ;Alexa Hetzel, MS, PA-C ;Vikash D. Oza, MD ;Amy Spizuoco, DO, FAOCD
September 30th 2025

Experts discuss the unique challenges of managing atopic dermatitis (AD) in pediatric and adolescent patients, emphasizing the strategic use of topical treatments to improve adherence, reduce long-term healthcare costs, and prevent disease progression through early, accessible, and individualized care.

Watch

© 2025 MJH Life Sciences
AJMC®
All rights reserved.